• 1. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 4. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

Introduction to 2-Methyl-5-(trifluoromethoxy)benzyl bromide (CAS No. 1261573-60-7)

2-Methyl-5-(trifluoromethoxy)benzyl bromide, identified by the Chemical Abstracts Service Number (CAS No.) 1261573-60-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the class of aryl alkyl bromides, characterized by its brominated benzyl group and the presence of a methyl substituent at the 2-position and a trifluoromethoxy group at the 5-position of the benzene ring. The unique structural features of this molecule make it a valuable intermediate in synthetic chemistry, particularly in the development of biologically active agents.

The bromine atom in 2-Methyl-5-(trifluoromethoxy)benzyl bromide serves as a reactive handle for further functionalization through cross-coupling reactions such as Suzuki-Miyaura, Stille, or Buchwald-Hartwig couplings. These reactions are pivotal in constructing complex molecular architectures, which are often essential for achieving high binding affinity and selectivity in drug candidates. The trifluoromethoxy group (CF?OCH?) is another key feature that imparts specific electronic and steric properties to the molecule. This group is known to enhance metabolic stability and improve lipophilicity, making it a desirable moiety in medicinal chemistry.

In recent years, there has been a surge in research focused on the development of novel therapeutic agents targeting various diseases, including cancer, inflammation, and infectious disorders. The structural motif present in 2-Methyl-5-(trifluoromethoxy)benzyl bromide has been explored in several lead optimization campaigns due to its potential to interact with biological targets through multiple mechanisms. For instance, derivatives of this compound have shown promise as inhibitors of kinases and other enzymes implicated in disease pathways.

One notable application of 2-Methyl-5-(trifluoromethoxy)benzyl bromide is in the synthesis of small-molecule probes for biochemical studies. Researchers have utilized this compound to develop tools that can modulate specific signaling pathways, providing insights into disease mechanisms and facilitating the discovery of new therapeutic strategies. The ability to introduce diverse functional groups via cross-coupling reactions allows for the generation of libraries of compounds that can be screened for biological activity.

The pharmaceutical industry has also leveraged the reactivity of 2-Methyl-5-(trifluoromethoxy)benzyl bromide in the development of novel drug candidates. For example, recent studies have demonstrated its utility in constructing heterocyclic scaffolds that exhibit potent activity against bacterial infections. The incorporation of fluorine atoms into drug molecules is a well-established strategy to improve pharmacokinetic properties, and the presence of multiple fluorine atoms in this compound may contribute to its stability and efficacy.

Moreover, advancements in computational chemistry have enabled researchers to predict the binding modes and interactions of 2-Methyl-5-(trifluoromethoxy)benzyl bromide with biological targets with greater accuracy. These computational studies have guided synthetic efforts toward optimizing potency and selectivity. By integrating experimental data with computational modeling, scientists can design more effective molecules tailored to specific therapeutic needs.

The synthesis of 2-Methyl-5-(trifluoromethoxy)benzyl bromide typically involves multi-step organic transformations starting from commercially available precursors. Key steps include halogenation, methylation, and functional group interconversions. The efficiency and scalability of these synthetic routes are crucial for industrial applications, where large quantities of high-purity material are often required.

In conclusion, 2-Methyl-5-(trifluoromethoxy)benzyl bromide (CAS No. 1261573-60-7) represents a versatile building block in pharmaceutical chemistry. Its unique structural features and reactivity make it an invaluable tool for synthetic chemists working on drug discovery and development. As research continues to uncover new applications for this compound, its importance in medicinal chemistry is likely to grow further.

• 261951-95-5(2-Methyl-4-(trifluoromethoxy)benzyl Bromide)
• 72768-95-7(1-(Bromomethyl)-3-(difluoromethoxy)benzene)
• 86256-51-1(3-Fluoro-5-(trifluoromethoxy)benzyl bromide)
• 3447-53-8(1-(bromomethyl)-4-(difluoromethoxy)benzene)
• 50824-05-0(4-(Trifluoromethoxy)benzyl bromide)
• 864055-32-3(BENZENE, 1-[3-(BROMOMETHYL)PHENOXY]-3-(TRIFLUOROMETHOXY)-)
• 478484-53-6(2-METHOXY-5-(TRIFLUOROMETHOXY)BENZYL BROMIDE)
• 916420-55-8(3-Methyl-5-(trifluoromethoxy)benzyl Bromide)
• 159689-88-0(3-(Bromomethyl)trifluoromethoxybenzene)
• 853771-92-3(4-Methoxy-3-(trifluoromethoxy)benzyl bromide)